ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 57 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2018. The put-call ratio across all filers is 3.82 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $20,000 | -37.5% | 15,000 | 0.0% | 0.00% | – |
| Q1 2019 | $32,000 | -5.9% | 15,000 | 0.0% | 0.00% | – |
| Q4 2018 | $34,000 | -35.8% | 15,000 | 0.0% | 0.00% | – |
| Q3 2018 | $53,000 | +51.4% | 15,000 | +36.4% | 0.00% | – |
| Q2 2018 | $35,000 | +66.7% | 11,000 | +83.3% | 0.00% | – |
| Q1 2018 | $21,000 | -47.5% | 6,000 | -33.3% | 0.00% | – |
| Q4 2017 | $40,000 | – | 9,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROW Partners, LLC | 325,000 | $2,077,000 | 1.27% |
| DAFNA Capital Management LLC | 125,000 | $799,000 | 0.82% |
| BARD ASSOCIATES INC | 170,925 | $1,094,000 | 0.46% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 525,000 | $3,355,000 | 0.36% |
| SOPHROSYNE CAPITAL LLC | 42,000 | $267,000 | 0.23% |
| Granite Point Capital Management, L.P. | 205,000 | $1,310,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 407,024 | $2,601,000 | 0.17% |
| SCOGGIN MANAGEMENT LP | 150,000 | $959,000 | 0.08% |
| Geduld E E | 25,000 | $160,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 45,000 | $288,000 | 0.05% |